ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Implants Don’t Cause Cancer, Long-Term Study Finds

May 26, 2006

Two Private Cancer Information Services Are Up and Running

May 13, 1988

“One Time Offer” On Comprehensiveness Approved By NCAB

September 22, 1989

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

In Brief: Simone Named New Director At St. Jude; Schein To Leave Georgetown For Job At Smith-Kline

September 16, 1983